Global Monoclonal Antibodies Market
According to the report “ Global Monoclonal Antibodies Market ”, published by Market Data Forecast , the global market is projected to reach USD 112175.5 million by 2021 , at a CAGR of 5.30 % from 2016 to 2021 .
mAb`s are antibodies produced by a single clone of cells consisting of identical antibody molecules . Global Monoclonal Antibodies market continues to gain momentum with the rapid increase in adoption of these products for various indications . At present , there are forty-seven monoclonal antibody products have been approved in the United States or Europe for the treatment of a wide range of diseases , and many of these products have also been approved in the global markets . At the current approval rate of four new products releasing every year , approximately 70 monoclonal antibody products are expected to be present on the market by 2021 .
Global Monoclonal Antibodies market is driven by increasing R & D activities in genomics , owing to rapid advancements of our understanding of disease at a molecular level . The development of new molecules is expected to play a prominent role in the future of the market due to the cost effectiveness of this technology . However huge cost and time associated with the identification and development of potential molecules is a major factor hindering the growth of the market .
The Global Market for Monoclonal Antibodies is broadly categorized by Source , Indication , End User , Application and Region .
1 ) By source � � � �
Murine Chimeric Humanized Human
2 ) By Indication �
Cancer a ) Blood Cancer b ) Breast Cancer c ) Colorectal Cancer d ) Lung Cancer e ) Pancreatic Cancer f ) Others
+ 1 888-702-9626 | www . marketdataforecast . com | contact @ marketdataforecast . com